Axogen, Inc. AXGN
49.50 USD -0.35 (-0.70%)
At closeNov 3, 2026, 6:30 PM EST
49.50 0.00 0.00%
After hours · Nov 3, 6:30 PM ET
49.18 Day range 50.84
22.92 52-week range 52.91
- YTD
- +51.24%
- 1 year
- +112.90%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 59.09 +19.4% upside
Now 49.50
- Target (low)
- 56.00
- Target (mean)
- 59.09
- Target (high)
- 65.00
Ratings (0m) 11 11 buy · 0 hold · 0 sell
- Strong buy2
- Buy9
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 10
- 2 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.14567 | 0.10 – 0.22 | 0.07 | +108.1% | 83.34M | +39.1% | 9 |
| Next quarter | 0.13438 | 0.09 – 0.18 | 0.07 | +92.0% | 80.56M | +31.1% | 8 |
| Current year | 0.55433 | 0.51 – 0.63 | 0.29 | +91.2% | 290.36M | +28.9% | 9 |
| Next year | 0.70544 | 0.60 – 0.82 | 0.55433 | +27.3% | 372.70M | +28.4% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 29, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Oct 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 29, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 29, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 29, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 23, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 12, 2026 | B of A Securities | Initiated | — | Buy |
| Oct 7, 2026 | Barclays | Initiated | — | Overweight |
| Oct 1, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 25, 2026 | Raymond James | Maintained | Outperform | Outperform |
| Aug 26, 2026 | Truist Securities | Initiated | — | Buy |
| Jul 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 30, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jul 30, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 29, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Apr 29, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 29, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 23, 2026 | Lake Street | Maintained | Buy | Buy |
| Mar 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 24, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Feb 19, 2026 | Wells Fargo | Initiated | — | Overweight |
| Dec 5, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 5, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 4, 2025 | Jefferies | Maintained | Buy | Buy |
| Dec 4, 2025 | Lake Street | Maintained | Buy | Buy |
| Dec 1, 2025 | Mizuho | Initiated | — | Outperform |
| Oct 30, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 30, 2025 | Raymond James | Maintained | Outperform | Outperform |
